Literature DB >> 28427896

Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection.

Maryam Nemati1, Tiziana Larussa2, Hossein Khorramdelazad3, Merat Mahmoodi4, Abdollah Jafarzadeh5.   

Abstract

Toll like receptors (TLRs) are an essential subset of pathogen recognition receptors (PRRs) which identify the microbial components and contribute in the regulation of innate and adaptive immune responses against the infectious agents. The TLRs, especially TLR2, TLR4, TLR5 and TLR9, participate in the induction of immune response against H. pylori. TLR2 is expressed on a number of immune and non-immune cells and recognizes a vast broad of microbial components due to its potential to form heterodimers with other TLRs, including TLR1, TLR6 and TLR10. A number of H. pylori-related molecules may contribute to TLR2-dependent responses, including HP-LPS, HP-HSP60 and HP-NAP. TLR2 plays a pivotal role in regulation of immune response to H. pylori through activation of NF-κB and induction of cytokine expression in epithelial cells, monocytes/macrophages, dendritic cells, neutrophils and B cells. The TLR2-related immune response that is induced by H. pylori-derived components may play an important role regarding the outcome of the infection toward bacterial elimination, persistence or pathological reactions. The immunomodulatory and immunoregulatory roles of TLR2 during H. pylori infection were considered in this review. TLR2 could be considered as an interesting therapeutic target for treatment of H. pylori-related diseases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  H. pylori; Pathogen recognition receptor; TLR2

Mesh:

Substances:

Year:  2017        PMID: 28427896     DOI: 10.1016/j.lfs.2017.04.006

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis.

Authors:  Tian-Huei Chu; Shih-Tsung Huang; Sheau-Fang Yang; Chia-Jung Li; Hung-Wei Lin; Bi-Chuang Weng; Shih-Ming Yang; Shih-Chung Huang; Jian-Ching Wu; Yi-Chen Chang; Zhi-Hong Wen; Yi-Ming Arthur Chen; Wen-Jeng Wu; Mei-Lang Kung; Po-Han Tai; Deng-Chyang Wu; Ming-Hong Tai
Journal:  Oncogene       Date:  2019-07-22       Impact factor: 9.867

2.  The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan.

Authors:  Jerzy Maksymowicz; Anna Palko-Łabuz; Beata Sobieszczańska; Mateusz Chmielarz; Mirosława Ferens-Sieczkowska; Magdalena Skonieczna; Agnieszka Wikiera; Olga Wesołowska; Kamila Środa-Pomianek
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-09

3.  Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori.

Authors:  Tiziana Larussa; Serena Gervasi; Rita Liparoti; Evelina Suraci; Raffaella Marasco; Maria Imeneo; Francesco Luzza
Journal:  J Immunol Res       Date:  2018-10-08       Impact factor: 4.818

4.  Identification of New Genes Involved in Germline Predisposition to Early-Onset Gastric Cancer.

Authors:  Cristina Herrera-Pariente; Roser Capó-García; Marcos Díaz-Gay; Sabela Carballal; Jenifer Muñoz; Joan Llach; Ariadna Sánchez; Laia Bonjoch; Coral Arnau-Collell; Yasmin Soares de Lima; Mariano Golubicki; Gerhard Jung; Juan José Lozano; Antoni Castells; Francesc Balaguer; Luis Bujanda; Sergi Castellví-Bel; Leticia Moreira
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

5.  A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages.

Authors:  Camille Danne; Grigory Ryzhakov; Maria Martínez-López; Nicholas Edward Ilott; Fanny Franchini; Fiona Cuskin; Elisabeth C Lowe; Samuel J Bullers; J Simon C Arthur; Fiona Powrie
Journal:  Cell Host Microbe       Date:  2017-12-13       Impact factor: 21.023

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.